Mattern Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Hold
3,800
0.04% 171
2026
Q1
$230K Hold
3,800
0.04% 143
2025
Q4
$205K Buy
+3,800
New +$183K 0.04% 153
2025
Q3
Sell
-4,400
Closed -$204K 157
2025
Q2
$204K Hold
4,400
0.04% 159
2025
Q1
$268K Sell
4,400
-400
-8% -$23.3K 0.06% 135
2024
Q4
$272K Hold
4,800
0.06% 140
2024
Q3
$248K Buy
+4,800
New +$225K 0.05% 156
2024
Q2
Sell
-4,400
Closed -$239K 174
2024
Q1
$239K Hold
4,400
0.06% 159
2023
Q4
$226K Sell
4,400
-1,100
-20% -$57.7K 0.06% 160
2023
Q3
$319K Hold
5,500
0.09% 129
2023
Q2
$352K Hold
5,500
0.1% 124
2023
Q1
$381K Hold
5,500
0.13% 126
2022
Q4
$396K Hold
5,500
0.16% 115
2022
Q3
$391K Hold
5,500
0.16% 108
2022
Q2
$424K Hold
5,500
0.17% 102
2022
Q1
$402K Hold
5,500
0.13% 106
2021
Q4
$343K Sell
5,500
-100
-2% -$5.87K 0.1% 127
2021
Q3
$331K Buy
5,600
+100
+2% +$6.59K 0.11% 131
2021
Q2
$370K Hold
5,500
0.12% 129
2021
Q1
$347K Sell
5,500
-150
-3% -$9.33K 0.12% 125
2020
Q4
$350K Hold
5,650
0.13% 122
2020
Q3
$341K Hold
5,650
0.15% 117
2020
Q2
$332K Sell
5,650
-100
-2% -$5.98K 0.16% 109
2020
Q1
$321K Buy
+5,750
New +$351K 0.23% 95

Other funds holding BMY

Mattern Wealth Management's BMY Position: Q2 2026 in Review

Mattern Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,800 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #171.

Mattern Wealth Management first reported a position in BMY in Q1 2020 and has held it in 24 quarters since. The position peaked at $424K in Q2 2022. 831 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Mattern Wealth Management held 3,800 shares of Bristol-Myers Squibb worth $219K as of Q2 2026.
  • Mattern Wealth Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.04% of Mattern Wealth Management's portfolio in Q2 2026, its #171 holding.
  • Mattern Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 24 quarters since.
  • Mattern Wealth Management's Bristol-Myers Squibb position peaked at $424K in Q2 2022.
  • 831 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Mattern Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.